Clinical trial
International, Multicentre, Observational, Prospective, Longitudinal Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (AboLiSh)
NCT04050527 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- International, Multicentre, Observational, Prospective, Longitudinal Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (AboLiSh)
- Lead sponsor
- Ipsen
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 19, 2019
- Completion date
- July 29, 2022
- Enrollment
- 438 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
adult lower limb spasticity